ONCOLYTICS BIOTECH INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 CAD | -2.68% |
|
-6.45% | -18.99% |
| 15/05 | Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call | |
| 15/05 | Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Other Biotechnology & Medical Research | -2.68% | -6.45% | -18.99% | -39.83% | -42.69% | 8.27Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ONC Stock
- Charts Oncolytics Biotech Inc.
- Comparison Chart
